FDA 483 OBSERVATION · #71 OF 1,923 MOST-CITED
Manufacturing conditions
FDA cited this observation 350 times across 338 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this grouping is not
An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.
What this observation means, and how to comply
SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.
The general conditions under which food was manufactured, packed, or held did not protect it against contamination — this covers the sanitary conduct of operations under §117.80, including temperature and time control, protection against cross-contamination, and adequate handling of raw materials, work-in-process, rework, and finished food.
Why FDA writes it — Poor manufacturing conditions allow microbial growth, allergen carryover, and physical or chemical contamination to enter product that is then distributed. FDA cites this because §117.80 is the catch-all requirement that all reasonable precautions be taken so food is suitable and not adulterated during processing and holding.
- Establish and hold time/temperature parameters for steps where microbial growth or toxin formation is possible, and document that product stays within them.
- Segregate raw from ready-to-eat material and control the flow of people, equipment, and air to prevent cross-contamination and allergen carryover.
- Handle rework and returned material under defined controls so it cannot introduce hazards or unlabeled allergens into new lots.
- Monitor manufacturing conditions on a defined cadence and correct out-of-spec conditions before production continues.
- Operating parameters (time, temperature, segregation) never translated from the hazard analysis into enforced line practice.
- Production pressure overriding sanitary controls, with no line-clearance or condition check built into the workflow.
How to close this finding — and stop it recurring
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1.3× the rate of the average FDA-cited firm (10.4% vs 7.8%), across 338 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
Failure to manufacture foods under conditions and controls necessary to minimize contamination.
Failure to store foods under conditions and controls necessary to minimize the potential for growth of microorganisms and contamination.
Failure to manufacture foods under conditions and controls necessary to minimize contamination.
Failure to manufacture and store foods under conditions and controls necessary to minimize the potential for growth of microorganisms and contamination.
Failure to manufacture and package foods under conditions and controls necessary to minimize the potential for growth of microorganisms and contamination.
Failure to manufacture foods under conditions and controls necessary to minimize contamination.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →